Original Research
Published on 26 Oct 2023
Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study
in Alloimmunity and Transplantation
- 2,779 views
- 4 citations